WallStSmart

Aveanna Healthcare Holdings Inc (AVAH)vsThe Ensign Group Inc (ENSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 109% more annual revenue ($5.27B vs $2.52B). AVAH leads profitability with a 10.4% profit margin vs 6.9%. AVAH trades at a lower P/E of 7.0x. ENSG earns a higher WallStSmart Score of 63/100 (C+).

AVAH

Buy

62

out of 100

Grade: C+

Growth: 8.7Profit: 7.5Value: 5.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.95

ENSG

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.15
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVAHSignificantly Overvalued (-84.3%)

Margin of Safety

-84.3%

Fair Value

$4.33

Current Price

$8.48

$4.15 premium

UndervaluedFair: $4.33Overvalued
ENSGSignificantly Overvalued (-45.8%)

Margin of Safety

-45.8%

Fair Value

$145.35

Current Price

$165.74

$20.39 premium

UndervaluedFair: $145.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVAH4 strengths · Avg: 9.5/10
P/E RatioValuation
7.0x10/10

Attractively priced relative to earnings

Return on EquityProfitability
36.8%10/10

Every $100 of equity generates 37 in profit

EPS GrowthGrowth
612.0%10/10

Earnings expanding 612.0% YoY

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

ENSG2 strengths · Avg: 8.0/10
Revenue GrowthGrowth
18.4%8/10

18.4% revenue growth

EPS GrowthGrowth
21.9%8/10

Earnings expanding 21.9% YoY

Areas to Watch

AVAH4 concerns · Avg: 2.0/10
Market CapQuality
$1.84B3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-208,0002/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.952/10

Distress zone — elevated risk

Debt/EquityHealth
6.261/10

Elevated debt levels

ENSG2 concerns · Avg: 3.5/10
P/E RatioValuation
26.7x4/10

Moderate valuation

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AVAH

The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 15.9% demonstrates continued momentum.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth, EPS Growth. Revenue growth of 18.4% demonstrates continued momentum. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bear Case : AVAH

The primary concerns for AVAH are Market Cap, Free Cash Flow, Altman Z-Score. Debt-to-equity of 6.26 is elevated, increasing financial risk.

Bear Case : ENSG

The primary concerns for ENSG are P/E Ratio, Profit Margin.

Key Dynamics to Monitor

AVAH carries more volatility with a beta of 1.93 — expect wider price swings.

ENSG is growing revenue faster at 18.4% — sustainability is the question.

ENSG generates stronger free cash flow (65M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ENSG scores higher overall (63/100 vs 62/100) and 18.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aveanna Healthcare Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?